{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:15:47Z","timestamp":1785392147215,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03362-9","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T02:14:58Z","timestamp":1732328098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Carbonic anhydrase inhibitor alleviates retinal barrier toxicity in paclitaxel-induced retinopathy and macular edema by inhibiting CAXIV"],"prefix":"10.1007","volume":"44","author":[{"given":"Ya-ting","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-li","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-fang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-tong","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-jie","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,23]]},"reference":[{"key":"3362_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/bs.podrm.2018.11.001","volume":"44","author":"FY Alqahtani","year":"2019","unstructured":"Alqahtani FY, Aleanizy FS, El Tahir E, Alkahtani HM, AlQuadeib BT (2019) Paclitaxel. Profiles Drug Subst Excip Relat Methodol 44:205\u2013238. https:\/\/doi.org\/10.1016\/bs.podrm.2018.11.001","journal-title":"Profiles Drug Subst Excip Relat Methodol"},{"key":"3362_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/BF02968008","volume":"11","author":"H Hagiwara","year":"2004","unstructured":"Hagiwara H, Sunada Y (2004) Mechanism of taxane neurotoxicity. Breast Cancer 11:82\u201385. https:\/\/doi.org\/10.1007\/BF02968008","journal-title":"Breast Cancer"},{"key":"3362_CR3","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/bjc.1997.126","volume":"75","author":"ME Gore","year":"1997","unstructured":"Gore ME, Rustin G, Slevin M, Gallagher C, Penson R, Osborne R, Ledermann J, Cameron T, Thompson JM (1997) Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. London gynaecological oncology and north thames gynaecological oncology groups. Br J Cancer 75:710\u2013714. https:\/\/doi.org\/10.1038\/bjc.1997.126","journal-title":"Br J Cancer"},{"key":"3362_CR4","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/s41598-021-81398-y","volume":"11","author":"JCB Chiang","year":"2021","unstructured":"Chiang JCB, Goldstein D, Trinh T, Au K, Park SB, Krishnan AV, Markoulli M (2021) A cross-sectional study of ocular surface discomfort and corneal nerve dysfunction after paclitaxel treatment for cancer. Sci Rep 11:1786. https:\/\/doi.org\/10.1038\/s41598-021-81398-y","journal-title":"Sci Rep"},{"key":"3362_CR5","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1200\/JCO.2012.45.6574","volume":"31","author":"A Chan","year":"2013","unstructured":"Chan A, Su C, de Boer RH, Gajdatsy A (2013) Prevalence of excessive tearing in women with early breast cancer receiving adjuvant docetaxel-based chemotherapy. J Clin Oncol 31:2123\u20132127. https:\/\/doi.org\/10.1200\/JCO.2012.45.6574","journal-title":"J Clin Oncol"},{"key":"3362_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/01.IOP.0000075016.29682.E0","volume":"19","author":"B Esmaeli","year":"2003","unstructured":"Esmaeli B, Burnstine MA, Ahmadi MA, Prieto VG (2003) Docetaxel-induced histologic changes in the lacrimal sac and the nasal mucosa. Ophthalmic Plast Reconstr Surg 19:305\u2013308. https:\/\/doi.org\/10.1097\/01.IOP.0000075016.29682.E0","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"3362_CR7","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/cncr.11527","volume":"98","author":"B Esmaeli","year":"2003","unstructured":"Esmaeli B, Hidaji L, Adinin RB, Faustina M, Coats C, Arbuckle R, Rivera E, Valero V, Tu SM, Ahmadi MA (2003) Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy. Cancer 98:504\u2013507. https:\/\/doi.org\/10.1002\/cncr.11527","journal-title":"Cancer"},{"key":"3362_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/01.ICL.0000062464.79558.5A","volume":"29","author":"CA Skolnick","year":"2003","unstructured":"Skolnick CA, Doughman DJ (2003) Erosive conjunctivitis and punctal stenosis secondary to docetaxel (taxotere). Eye Contact Lens 29:134\u2013135. https:\/\/doi.org\/10.1097\/01.ICL.0000062464.79558.5A","journal-title":"Eye Contact Lens"},{"key":"3362_CR9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0140-6736(05)73228-1","volume":"355","author":"M del Pilar Bernal","year":"2000","unstructured":"del Pilar Bernal M, Loftfield K, Nussdorf JD (2000) Taxane-induced glaucoma. Lancet 355:577. https:\/\/doi.org\/10.1016\/S0140-6736(05)73228-1","journal-title":"Lancet"},{"key":"3362_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S0140-6736(99)03019-6","volume":"354","author":"E Fabre-Guillevin","year":"1999","unstructured":"Fabre-Guillevin E, Tchen N, Anibali-Charpiat MF, Calluaud L, Ravaud A (1999) Taxane-induced glaucoma. Lancet 354:1181\u20131182. https:\/\/doi.org\/10.1016\/S0140-6736(99)03019-6","journal-title":"Lancet"},{"key":"3362_CR11","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1200\/JCO.1994.12.8.1741","volume":"12","author":"AD Seidman","year":"1994","unstructured":"Seidman AD, Barrett S, Canezo S (1994) Photopsia during 3\u00a0hour paclitaxel administration at doses > or = 250\u00a0mg\/m2. J Clin Oncol 12:1741\u20131742. https:\/\/doi.org\/10.1200\/JCO.1994.12.8.1741","journal-title":"J Clin Oncol"},{"key":"3362_CR12","first-page":"777","volume":"43","author":"Y Noguchi","year":"2016","unstructured":"Noguchi Y, Kawashima Y, Kawara H, Kaneko M, Nakauchi H, Tokuyama Y (2016) An undeniable case of optic neuropathy due to cabazitaxel. Gan To Kagaku Ryoho 43:777\u2013779","journal-title":"Gan To Kagaku Ryoho"},{"key":"3362_CR13","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12886-019-1246-3","volume":"19","author":"X Yuan","year":"2019","unstructured":"Yuan X, Feng Y, Li D, Li M (2019) Unilateral visual impairment in a patient undergoing chemotherapy: a case report and clinical findings. BMC Ophthalmol 19:236. https:\/\/doi.org\/10.1186\/s12886-019-1246-3","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"3362_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/15569527.2020.1790592","volume":"39","author":"M Kaya","year":"2020","unstructured":"Kaya M, Atas F, Guc ZG, Oztop I, Durak I, Saatci AO (2020) A cross-sectional optical coherence tomography study in patients on taxane-based therapy and a case report with the literature review. Cutan Ocul Toxicol 39(3):287\u2013293. https:\/\/doi.org\/10.1080\/15569527.2020.1790592","journal-title":"Cutan Ocul Toxicol"},{"key":"3362_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10384-017-0552-7","volume":"62","author":"N Nomi","year":"2018","unstructured":"Nomi N, Ota M, Fukumura M, Nuno Y, Hatano M, Wakuta M, Yanai R, Kimura K (2018) Indocyanine green angiography findings of cystoid macular edema secondary to paclitaxel therapy. Jpn J Ophthalmol 62:163\u2013167. https:\/\/doi.org\/10.1007\/s10384-017-0552-7","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"3362_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.20344\/amp.13421","volume":"35","author":"SA Pereira","year":"2022","unstructured":"Pereira SA, Vale C, Moreira J, Sampaio F (2022) Macular cystoid edema induced by nab-paclitaxel. Acta Med Port 35(4):294\u2013297. https:\/\/doi.org\/10.20344\/amp.13421","journal-title":"Acta Med Port"},{"key":"3362_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s13256-021-02954-8","volume":"15","author":"M Otsubo","year":"2021","unstructured":"Otsubo M, Kinouchi R, Kamiya T, Yoshida A (2021) Regression of taxane-related cystoid macular edema after topical dorzolamide treatment: two case reports. J Med Case Rep 15:355. https:\/\/doi.org\/10.1186\/s13256-021-02954-8","journal-title":"J Med Case Rep"},{"key":"3362_CR18","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.4103\/ijo.IJO_1240_18","volume":"66","author":"DJ Browning","year":"2018","unstructured":"Browning DJ, Stewart MW, Lee C (2018) Diabetic macular edema: evidence-based management. Indian J Ophthalmol 66:1736\u20131750. https:\/\/doi.org\/10.4103\/ijo.IJO_1240_18","journal-title":"Indian J Ophthalmol"},{"key":"3362_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073427","author":"H Noma","year":"2021","unstructured":"Noma H, Yasuda K, Shimura M (2021) Involvement of cytokines in the pathogenesis of diabetic macular edema. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22073427","journal-title":"Int J Mol Sci"},{"key":"3362_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3892\/mco.2017.1296","volume":"7","author":"E Bassi","year":"2017","unstructured":"Bassi E, Loizzi V, Furino C, Martino R, Alessio G, Ettore C, Cormio G (2017) Cystoid macular edema secondary to paclitaxel therapy for ovarian cancer: a case report. Mol Clin Oncol 7:285\u2013287. https:\/\/doi.org\/10.3892\/mco.2017.1296","journal-title":"Mol Clin Oncol"},{"key":"3362_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1684\/ejd.2016.2833","volume":"26","author":"V Sibaud","year":"2016","unstructured":"Sibaud V, Leb\u0153uf NR, Roche H, Belum VR, Gladieff L, Deslandres M, Montastruc M, Eche A, Vigarios E, Dalenc F, Lacouture ME (2016) Dermatological adverse events with taxane chemotherapy. Eur J Dermatol 26:427\u2013443. https:\/\/doi.org\/10.1684\/ejd.2016.2833","journal-title":"Eur J Dermatol"},{"issue":"Suppl 1","key":"3362_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000315155","volume":"224","author":"S Scholl","year":"2010","unstructured":"Scholl S, Kirchhof J, Augustin AJ (2010) Pathophysiology of macular edema. Ophthalmologica 224(Suppl 1):8\u201315. https:\/\/doi.org\/10.1159\/000315155","journal-title":"Ophthalmologica"},{"key":"3362_CR23","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/archopht.125.5.709","volume":"125","author":"MM Joshi","year":"2007","unstructured":"Joshi MM, Garretson BR (2007) Paclitaxel maculopathy. Arch Ophthalmol 125:709\u2013710. https:\/\/doi.org\/10.1001\/archopht.125.5.709","journal-title":"Arch Ophthalmol"},{"key":"3362_CR24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3341\/kjo.2012.26.5.394","volume":"26","author":"NK Koo","year":"2012","unstructured":"Koo NK, Kim YC (2012) A case of paclitaxel-induced maculopathy treated with methazolamide. Korean J Ophthalmol 26:394\u2013397. https:\/\/doi.org\/10.3341\/kjo.2012.26.5.394","journal-title":"Korean J Ophthalmol"},{"key":"3362_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1023\/a:1002143802926","volume":"97","author":"TJ Wolfensberger","year":"1999","unstructured":"Wolfensberger TJ (1999) The role of carbonic anhydrase inhibitors in the management of macular edema. Doc Ophthalmol 97:387\u2013397. https:\/\/doi.org\/10.1023\/a:1002143802926","journal-title":"Doc Ophthalmol"},{"issue":"26","key":"3362_CR26","doi-asserted-by":"publisher","first-page":"e11229","DOI":"10.1097\/MD.0000000000011229","volume":"97","author":"CH Shih","year":"2018","unstructured":"Shih CH, Lee YC (2018) Impaired retinal pigment epithelium in paclitaxel-induced macular edema: a case report. Medicine (Baltimore) 97(26):e11229. https:\/\/doi.org\/10.1097\/MD.0000000000011229","journal-title":"Medicine (Baltimore)"},{"key":"3362_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5","volume":"26","author":"EA Nagelhus","year":"1999","unstructured":"Nagelhus EA, Horio Y, Inanobe A, Fujita A, Haug FM, Nielsen S, Kurachi Y, Ottersen OP (1999) Immunogold evidence suggests that coupling of K+ siphoning and water transport in rat retinal M\u00fcller cells is mediated by a coenrichment of Kir4.1 and AQP4 in specific membrane domains. Glia 26:47\u201354","journal-title":"Glia"},{"key":"3362_CR28","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1096\/fj.04-1723fje","volume":"18","author":"MC Papadopoulos","year":"2004","unstructured":"Papadopoulos MC, Manley GT, Krishna S, Verkman AS (2004) Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. Faseb J 18:1291\u20131293. https:\/\/doi.org\/10.1096\/fj.04-1723fje","journal-title":"Faseb J"},{"key":"3362_CR29","first-page":"194","volume":"5","author":"YT Ye","year":"2022","unstructured":"Ye YT (2022) Damage of retinal pigment epithelial cells function by paclitaxel and its potential mechanism [J]. Int Eye Sci 5:194\u2013199","journal-title":"Int Eye Sci"},{"key":"3362_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/ICB.0000000000000433","volume":"12","author":"R Dwivedi","year":"2018","unstructured":"Dwivedi R, Tiroumal S (2018) Possible efficacy of topical dorzolamide in the treatment of paclitaxel-related cystoid macular edema. Retin Cases Brief Rep 12:75\u201379. https:\/\/doi.org\/10.1097\/ICB.0000000000000433","journal-title":"Retin Cases Brief Rep"},{"key":"3362_CR31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/eye.2012.228","volume":"27","author":"JP Ehlers","year":"2013","unstructured":"Ehlers JP, Rayess H, Steinle N (2013) Topical dorzolamide therapy for taxane-related macular oedema. Eye (Lond) 27:102\u2013104. https:\/\/doi.org\/10.1038\/eye.2012.228","journal-title":"Eye (Lond)"},{"key":"3362_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/17425255.2020.1743679","volume":"16","author":"CT Supuran","year":"2020","unstructured":"Supuran CT (2020) An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. Expert Opin Drug Metab Toxicol 16:297\u2013307","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3362_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/978-94-007-7359-2_17","volume":"75","author":"A Scozzafava","year":"2014","unstructured":"Scozzafava A, Supuran CT (2014) Glaucoma and the applications of carbonic anhydrase inhibitors. Subcell Biochem 75:349\u2013359. https:\/\/doi.org\/10.1007\/978-94-007-7359-2_17","journal-title":"Subcell Biochem"},{"key":"3362_CR34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/bjophthalmol-2017-311392","volume":"103","author":"SA Strong","year":"2019","unstructured":"Strong SA, Hirji N, Quartilho A, Kalitzeos A, Michaelides M (2019) Retrospective cohort study exploring whether an association exists between spatial distribution of cystoid spaces in cystoid macular oedema secondary to retinitis pigmentosa and response to treatment with carbonic anhydrase inhibitors. Br J Ophthalmol 103:233\u2013237. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311392","journal-title":"Br J Ophthalmol"},{"key":"3362_CR35","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/1471-2474-13-256","volume":"13","author":"Y Zheng","year":"2012","unstructured":"Zheng Y, Wang L, Zhang W, Xu H, Chang X (2012) Transgenic mice over-expressing carbonic anhydrase I showed aggravated joint inflammation and tissue destruction. BMC Musculoskelet Disord 13:256. https:\/\/doi.org\/10.1186\/1471-2474-13-256","journal-title":"BMC Musculoskelet Disord"},{"key":"3362_CR36","doi-asserted-by":"publisher","first-page":"e0118273","DOI":"10.1371\/journal.pone.0118273","volume":"10","author":"GZ Zhuang","year":"2015","unstructured":"Zhuang GZ, Keeler B, Grant J, Bianchi L, Fu ES, Zhang YP, Erasso DM, Cui JG, Wiltshire T, Li Q, Hao S, Sarantopoulos KD, Candiotti K, Wishnek SM, Smith SB, Maixner W, Diatchenko L, Martin ER, Levitt RC (2015) Carbonic anhydrase-8 regulates inflammatory pain by inhibiting the ITPR1-cytosolic free calcium pathway. PLoS ONE 10:e0118273. https:\/\/doi.org\/10.1371\/journal.pone.0118273","journal-title":"PLoS ONE"},{"key":"3362_CR37","first-page":"3401","volume":"35","author":"TJ Wolfensberger","year":"1994","unstructured":"Wolfensberger TJ, Mahieu I, Jarvis-Evans J, Boulton M, Carter ND, N\u00f3gr\u00e1di A, Hollande E, Bird AC (1994) Membrane-bound carbonic anhydrase in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 35:3401\u20133407","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3362_CR38","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.exer.2005.03.010","volume":"81","author":"JD Ochrietor","year":"2005","unstructured":"Ochrietor JD, Clamp MF, Moroz TP, Grubb JH, Shah GN, Waheed A, Sly WS, Linser PJ (2005) Carbonic anhydrase XIV identified as the membrane CA in mouse retina: strong expression in M\u00fcller cells and the RPE. Exp Eye Res 81:492\u2013500. https:\/\/doi.org\/10.1016\/j.exer.2005.03.010","journal-title":"Exp Eye Res"},{"key":"3362_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s004170050013","volume":"238","author":"TJ Wolfensberger","year":"2000","unstructured":"Wolfensberger TJ, Chiang RK, Takeuchi A, Marmor MF (2000) Inhibition of membrane-bound carbonic anhydrase enhances subretinal fluid absorption and retinal adhesiveness. Graefes Arch Clin Exp Ophthalmol 238:76\u201380. https:\/\/doi.org\/10.1007\/s004170050013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3362_CR40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1023\/a:1002496223131","volume":"97","author":"TJ Wolfensberger","year":"1999","unstructured":"Wolfensberger TJ, Dmitriev AV, Govardovskii VI (1999) Inhibition of membrane-bound carbonic anhydrase decreases subretinal pH and volume. Doc Ophthalmol 97:261\u2013271. https:\/\/doi.org\/10.1023\/a:1002496223131","journal-title":"Doc Ophthalmol"},{"key":"3362_CR41","doi-asserted-by":"publisher","first-page":"8030","DOI":"10.1073\/pnas.0503021102","volume":"102","author":"EA Nagelhus","year":"2005","unstructured":"Nagelhus EA, Mathiisen TM, Bateman AC, Haug FM, Ottersen OP, Grubb JH, Waheed A, Sly WS (2005) Carbonic anhydrase XIV is enriched in specific membrane domains of retinal pigment epithelium, Muller cells, and astrocytes. Proc Natl Acad Sci U S A 102:8030\u20138035. https:\/\/doi.org\/10.1073\/pnas.0503021102","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03362-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03362-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03362-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:38:57Z","timestamp":1741880337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03362-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,23]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3362"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03362-9","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,23]]},"assertion":[{"value":"26 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"In this study, we used ARPE-19 cells (CRL-2302), Which were purchased from the American Type Culture Collection (Manassas, VA, USA). The number of cell line is 1\u00a0ml suspension, but we don\u2019t know the cell batch. This study was approved by the Laboratory Animal Management and Ethics Committee, Northwestern University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"437"}}